ImmunoCellular Therapeutics Ltd

FRA:KOL1 (USA)  
(Delisted) € 0.04 (0%) Nov 7
At Loss
Market Cap:
€ 1.17M ($ 1.27M)
Enterprise V:
€ 1.17M ($ 1.27M)
Volume:
-
Avg Vol (2M):
-

Business Description

Description
EOM Pharmaceutical Holdings Inc is a clinical-stage biotechnology company that is focused on developing drugs with the potential to transform therapeutic paradigms and improve the lives of patients suffering from debilitating and sometimes deadly diseases. Its pipeline includes compound EOM613, an investigational novel dynamically dual-acting immunomodulator. EOM613 is a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad-spectrum cytokine effects.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
14-Day RSI 10.92
6-1 Month Momentum % -9.52
12-1 Month Momentum % -34.48

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials

FRA:KOL1's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ImmunoCellular Therapeutics Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €)
EPS (TTM) (€) 0.396
Beta 0
Volatility % 78.65
14-Day RSI 10.92
14-Day ATR (€) 0
20-Day SMA (€) 0.07
12-1 Month Momentum % -34.48
52-Week Range (€) 0.03 - 0.57
Shares Outstanding (Mil) 41.93

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ImmunoCellular Therapeutics Ltd Filings

Filing Date Document Date Form
No Filing Data

ImmunoCellular Therapeutics Ltd Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

ImmunoCellular Therapeutics Ltd Frequently Asked Questions

What is ImmunoCellular Therapeutics Ltd(FRA:KOL1)'s stock price today?
The current price of FRA:KOL1 is €0.04. The 52 week high of FRA:KOL1 is €0.57 and 52 week low is €0.03.
When is next earnings date of ImmunoCellular Therapeutics Ltd(FRA:KOL1)?
The next earnings date of ImmunoCellular Therapeutics Ltd(FRA:KOL1) is .
Does ImmunoCellular Therapeutics Ltd(FRA:KOL1) pay dividends? If so, how much?
ImmunoCellular Therapeutics Ltd(FRA:KOL1) does not pay dividend.

Press Release

Subject Date
No Press Release